{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T23:32:59Z","timestamp":1780356779699,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["5R01MH114657-02"],"award-info":[{"award-number":["5R01MH114657-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["5R01MH114657-02"],"award-info":[{"award-number":["5R01MH114657-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["5R01MH114657-02"],"award-info":[{"award-number":["5R01MH114657-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["5R01MH114657-02"],"award-info":[{"award-number":["5R01MH114657-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["5R01MH114657-02"],"award-info":[{"award-number":["5R01MH114657-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["R25MH083620"],"award-info":[{"award-number":["R25MH083620"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000025","name":"National Institutes of Mental Health","doi-asserted-by":"crossref","award":["5R01MH114657-02"],"award-info":[{"award-number":["5R01MH114657-02"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Providence\/Boston Center for AIDS Research","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}]},{"name":"Providence\/Boston Center for AIDS Research","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23MH124539-01A1"],"award-info":[{"award-number":["K23MH124539-01A1"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pre-exposure prophylaxis (PrEP) can significantly reduce HIV acquisition especially among communities with high HIV prevalence, including men who have sex with men (MSM). Much research has been finding suboptimal PrEP persistence; however, few studies examine factors that enhance PrEP persistence in real-world settings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We interviewed 33 patients who identified as MSM at three different PrEP clinics in three regions of the U.S. (Northeast, South, Midwest). Participants were eligible if they took PrEP and had been retained in care for a minimum of 6\u00a0months. Interviews explored social, structural, clinic-level and behavioral factors that influencing PrEP persistence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Through thematic analysis we identified the following factors as promoting PrEP persistence: (1) navigation to reduce out-of-pocket costs of PrEP (structural), (2) social norms that support PrEP use (social), (3) access to LGBTQ\u2009+\u2009affirming medical providers (clinical), (4) medication as part of a daily routine (behavioral), and (5) facilitation of sexual health agency (belief).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>In this sample, persistence in PrEP care was associated with structural and social supports as well as a high level of perceived internal control over protecting their health by taking PrEP. Patients might benefit from increased access, LGBTQ\u2009+\u2009affirming medical providers, and communications that emphasize PrEP can promote sexual health.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07658-y","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T10:07:22Z","timestamp":1659694042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Facilitators for retaining men who have sex with men in pre-exposure prophylaxis care in real world clinic settings within the United States"],"prefix":"10.1186","volume":"22","author":[{"given":"Brooke G.","family":"Rogers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sosnowy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zanowick-Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. A.","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. C.","family":"Goedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Galipeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Curoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Underwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gomillia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. S.","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"issue":"5","key":"7658_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJMoa1110711","volume":"367","author":"MC Thigpen","year":"2012","unstructured":"Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1110711.","journal-title":"N Engl J Med"},{"issue":"27","key":"7658_CR2","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","volume":"363","author":"RM Grant","year":"2010","unstructured":"Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587\u201399. https:\/\/doi.org\/10.1056\/NEJMoa1011205.","journal-title":"N Engl J Med"},{"issue":"9","key":"7658_CR3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14(9):820\u20139. https:\/\/doi.org\/10.1016\/S1473-3099(14)70847-3.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"7658_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1056\/NEJMc1210464","volume":"368","author":"JM Baeten","year":"2013","unstructured":"Baeten JM, Celum C. Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med. 2013;368(1):83\u20134. https:\/\/doi.org\/10.1056\/NEJMc1210464.","journal-title":"N Engl J Med"},{"key":"7658_CR5","unstructured":"HIV Surveillance Report, 2017; Vol 29. Centers for Disease Control and Prevention. 2018. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed November 10, 2019."},{"issue":"9","key":"7658_CR6","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1007\/s10461-014-0845-5","volume":"18","author":"HL King","year":"2014","unstructured":"King HL, Keller SB, Giancola MA, et al. Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study). AIDS Behav. 2014;18(9):1722\u20135. https:\/\/doi.org\/10.1007\/s10461-014-0845-5.","journal-title":"AIDS Behav"},{"issue":"3","key":"7658_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033119","volume":"7","author":"DS Krakower","year":"2012","unstructured":"Krakower DS, Mimiaga MJ, Rosenberger JG, et al. Limited awareness and low immediate uptake of pre-exposure prophylaxis among men who have sex with men using an internet social networking site. PLoS ONE. 2012;7(3): e33119. https:\/\/doi.org\/10.1371\/journal.pone.0033119.","journal-title":"PLoS ONE"},{"issue":"1","key":"7658_CR8","doi-asserted-by":"publisher","first-page":"20903","DOI":"10.7448\/IAS.19.1.20903","volume":"19","author":"PA Chan","year":"2016","unstructured":"Chan PA, Mena L, Patel R, et al. Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. J Int AIDS Soc. 2016;19(1):20903. https:\/\/doi.org\/10.7448\/IAS.19.1.20903.","journal-title":"J Int AIDS Soc"},{"issue":"8","key":"7658_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25385","volume":"22","author":"PA Chan","year":"2019","unstructured":"Chan PA, Patel RR, Mena L, et al. Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States. J Int AIDS Soc. 2019;22(8): e25385. https:\/\/doi.org\/10.1002\/jia2.25385.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"7658_CR10","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1007\/s10461-017-2009-x","volume":"22","author":"JC Hojilla","year":"2018","unstructured":"Hojilla JC, Vlahov D, Crouch PC, Dawson-Rose C, Freeborn K, Carrico A. HIV pre-exposure prophylaxis (PrEP) uptake and retention among men who have sex with men in a community-based sexual health clinic. AIDS Behav. 2018;22(4):1096\u20139. https:\/\/doi.org\/10.1007\/s10461-017-2009-x.","journal-title":"AIDS Behav"},{"issue":"2","key":"7658_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25252","volume":"22","author":"KC Coy","year":"2019","unstructured":"Coy KC, Hazen RJ, Kirkham HS, Delpino A, Siegler AJ. Persistence on HIV preexposure prophylaxis medication over a 2-year period among a national sample of 7148 PrEP users, United States, 2015 to 2017. J Int AIDS Soc. 2019;22(2): e25252. https:\/\/doi.org\/10.1002\/jia2.25252.","journal-title":"J Int AIDS Soc"},{"issue":"3","key":"7658_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/cid\/ciz896","volume":"71","author":"MA Spinelli","year":"2020","unstructured":"Spinelli MA, Buchbinder SP. Pre-exposure prophylaxis persistence is a critical issue in PrEP implementation. Clin Infect Dis. 2020;71(3):583\u20135. https:\/\/doi.org\/10.1093\/cid\/ciz896.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"7658_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-005717","volume":"4","author":"I Young","year":"2014","unstructured":"Young I, Flowers P, McDaid LM. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland. BMJ Open. 2014;4(11): e005717. https:\/\/doi.org\/10.1136\/bmjopen-2014-005717.","journal-title":"BMJ Open"},{"issue":"10","key":"7658_CR14","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s10461-019-02641-2","volume":"23","author":"O Ezennia","year":"2019","unstructured":"Ezennia O, Geter A, Smith DK. The PrEP care continuum and black men who have sex with men: a scoping review of published data on awareness, uptake, adherence, and retention in PrEP care. AIDS Behav. 2019;23(10):2654\u201373. https:\/\/doi.org\/10.1007\/s10461-019-02641-2.","journal-title":"AIDS Behav"},{"issue":"6","key":"7658_CR15","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1177\/1557988318797437","volume":"12","author":"A Dubov","year":"2018","unstructured":"Dubov A, Galbo P, Altice FL, Fraenkel L. Stigma and shame experiences by MSM who take PrEP for HIV prevention: a qualitative study. Am J Mens Health. 2018;12(6):1843\u201354. https:\/\/doi.org\/10.1177\/1557988318797437.","journal-title":"Am J Mens Health"},{"issue":"2","key":"7658_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172354","volume":"12","author":"T Arnold","year":"2017","unstructured":"Arnold T, Brinkley-Rubinstein L, Chan PA, et al. Social, structural, behavioral and clinical factors influencing retention in pre-exposure prophylaxis (PrEP) care in Mississippi. PLoS ONE. 2017;12(2): e0172354. https:\/\/doi.org\/10.1371\/journal.pone.0172354.","journal-title":"PLoS ONE"},{"issue":"6","key":"7658_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s11121-017-0799-8","volume":"18","author":"ED Storholm","year":"2017","unstructured":"Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737\u201347. https:\/\/doi.org\/10.1007\/s11121-017-0799-8.","journal-title":"Prev Sci"},{"issue":"10","key":"7658_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/apc.2013.0116","volume":"27","author":"HJ Gilmore","year":"2013","unstructured":"Gilmore HJ, Liu A, Koester KA, et al. Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco. AIDS Patient Care STDs. 2013;27(10):560\u20136. https:\/\/doi.org\/10.1089\/apc.2013.0116.","journal-title":"AIDS Patient Care STDs"},{"issue":"7","key":"7658_CR19","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1007\/s10461-019-02397-9","volume":"23","author":"RA Brooks","year":"2019","unstructured":"Brooks RA, Landrian A, Nieto O, Fehrenbacher A. Experiences of anticipated and enacted pre-exposure prophylaxis (PrEP) stigma among Latino MSM in Los Angeles. AIDS Behav. 2019;23(7):1964\u201373. https:\/\/doi.org\/10.1007\/s10461-019-02397-9.","journal-title":"AIDS Behav"},{"issue":"2","key":"7658_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cid\/ciy160","volume":"67","author":"LK Rusie","year":"2018","unstructured":"Rusie LK, Orengo C, Burrell D, et al. Preexposure prophylaxis initiation and retention in care over 5 years, 2012\u20132017: are quarterly visits too much? Clin Infect Dis. 2018;67(2):283\u20137. https:\/\/doi.org\/10.1093\/cid\/ciy160.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"7658_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178737","volume":"12","author":"RR Patel","year":"2017","unstructured":"Patel RR, Mena L, Nunn A, et al. Impact of insurance coverage on utilization of pre-exposure prophylaxis for HIV prevention. PLoS ONE. 2017;12(5): e0178737. https:\/\/doi.org\/10.1371\/journal.pone.0178737.","journal-title":"PLoS ONE"},{"issue":"11","key":"7658_CR22","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1007\/s10461-018-2045-1","volume":"22","author":"THF Whitfield","year":"2018","unstructured":"Whitfield THF, John SA, Rendina HJ, Grov C, Parsons JT. Why I quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual men. AIDS Behav. 2018;22(11):3566\u201375. https:\/\/doi.org\/10.1007\/s10461-018-2045-1.","journal-title":"AIDS Behav"},{"issue":"3","key":"7658_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/cid\/ciz894","volume":"71","author":"DP Serota","year":"2020","unstructured":"Serota DP, Rosenberg ES, Sullivan PS, et al. Pre-exposure prophylaxis uptake and discontinuation among young black men who have sex with men in Atlanta, Georgia: a prospective cohort study. Clin Infect Dis. 2020;71(3):574\u201382. https:\/\/doi.org\/10.1093\/cid\/ciz894.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"7658_CR24","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1007\/s10461-019-02502-y","volume":"23","author":"S Wood","year":"2019","unstructured":"Wood S, Gross R, Shea JA, et al. Barriers and facilitators of PrEP adherence for young men and transgender women of color. AIDS Behav. 2019;23(10):2719\u201329. https:\/\/doi.org\/10.1007\/s10461-019-02502-y.","journal-title":"AIDS Behav"},{"issue":"4","key":"7658_CR25","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1089\/apc.2012.0419","volume":"27","author":"SA Golub","year":"2013","unstructured":"Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248\u201354. https:\/\/doi.org\/10.1089\/apc.2012.0419.","journal-title":"AIDS Patient Care STDs"},{"issue":"14","key":"7658_CR26","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.3390\/ijerph16142620","volume":"16","author":"L Peng","year":"2019","unstructured":"Peng L, Cao W, Gu J, et al. Willingness to use and adhere to HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China. Int J Environ Res Public Health. 2019;16(14):2620. https:\/\/doi.org\/10.3390\/ijerph16142620.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"7658_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1080\/09540121.2017.1360992","volume":"30","author":"EF Closson","year":"2018","unstructured":"Closson EF, Mitty JA, Malone J, Mayer KH, Mimiaga MJ. Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study. AIDS Care. 2018;30(2):191\u20138. https:\/\/doi.org\/10.1080\/09540121.2017.1360992.","journal-title":"AIDS Care"},{"issue":"7","key":"7658_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10461-015-1055-5","volume":"20","author":"J Carlo Hojilla","year":"2016","unstructured":"Carlo Hojilla J, Koester KA, Cohen SE, et al. Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: a qualitative analysis of counseling notes. AIDS Behav. 2016;20(7):1461\u20139. https:\/\/doi.org\/10.1007\/s10461-015-1055-5.","journal-title":"AIDS Behav"},{"issue":"Suppl 1","key":"7658_CR29","first-page":"A201","volume":"95","author":"T Punchihewa","year":"2019","unstructured":"Punchihewa T, Saxton P, Wiles J. \u201cThe promise of PrEP\u201d: motivations for taking PrEP among early-adopting New Zealand gay and bisexual men. Sex Transm Infect. 2019;95(Suppl 1):A201.","journal-title":"Sex Transm Infect"},{"issue":"1","key":"7658_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/19317611.2016.1206051","volume":"29","author":"SP Collins","year":"2017","unstructured":"Collins SP, McMahan VM, Stekler JD. The impact of HIV pre-exposure prophylaxis (PrEP) use on the sexual health of men who have sex with men: a qualitative study in Seattle, WA. Int J Sex Health. 2017;29(1):55\u201368. https:\/\/doi.org\/10.1080\/19317611.2016.1206051.","journal-title":"Int J Sex Health"},{"issue":"4","key":"7658_CR31","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC. Code saturation versus meaning saturation: how many interviews are enough? Qual Health Res. 2017;27(4):591\u2013608. https:\/\/doi.org\/10.1177\/1049732316665344.","journal-title":"Qual Health Res"},{"issue":"2","key":"7658_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1098214005283748","volume":"27","author":"DR Thomas","year":"2006","unstructured":"Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237\u201346. https:\/\/doi.org\/10.1177\/1098214005283748.","journal-title":"Am J Eval"},{"issue":"7","key":"7658_CR33","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s10461-018-2376-y","volume":"23","author":"SA Golub","year":"2019","unstructured":"Golub SA, Fikslin RA, Goldberg MH, Pe\u00f1a SM, Radix A. Predictors of PrEP uptake among patients with equivalent access. AIDS Behav. 2019;23(7):1917\u201324. https:\/\/doi.org\/10.1007\/s10461-018-2376-y.","journal-title":"AIDS Behav"},{"issue":"2","key":"7658_CR34","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/tbm\/ibz191","volume":"11","author":"AB D\u2019Angelo","year":"2021","unstructured":"D\u2019Angelo AB, Lopez-Rios J, Flynn AWP, Holloway IW, Pantalone DW, Grov C. Insurance- and medical provider-related barriers and facilitators to staying on PrEP: results from a qualitative study. Transl Behav Med. 2021;11(2):573\u201381. https:\/\/doi.org\/10.1093\/tbm\/ibz191.","journal-title":"Transl Behav Med"},{"issue":"5","key":"7658_CR35","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Ther. 2020;37(5):1778\u2013811. https:\/\/doi.org\/10.1007\/s12325-020-01295-0.","journal-title":"Adv Ther"},{"issue":"1","key":"7658_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2105\/AJPH.2019.305389","volume":"110","author":"ES Kay","year":"2020","unstructured":"Kay ES, Pinto RM. Is insurance a barrier to HIV preexposure prophylaxis? Clarifying the issue. Am J Public Health. 2020;110(1):61\u20134. https:\/\/doi.org\/10.2105\/AJPH.2019.305389.","journal-title":"Am J Public Health"},{"issue":"1","key":"7658_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11904-019-00429-6","volume":"16","author":"B Adamson","year":"2019","unstructured":"Adamson B, Lipira L, Katz AB. The impact of ACA and medicaid expansion on progress toward UNAIDS 90\u201390-90 goals. Curr HIV\/AIDS Rep. 2019;16(1):105\u201312. https:\/\/doi.org\/10.1007\/s11904-019-00429-6.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"7658_CR38","doi-asserted-by":"publisher","unstructured":"Keith K. New guidance on PrEP: support services must be covered without cost-sharing. Following the ACA. Published July 28, 2021. https:\/\/www.healthaffairs.org. doi: https:\/\/doi.org\/10.1377\/hblog20210728.333084. Accessed Nov 8, 2021.","DOI":"10.1377\/hblog20210728.333084"},{"issue":"3","key":"7658_CR39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/QAI.0000000000001497","volume":"76","author":"CP Rolle","year":"2017","unstructured":"Rolle CP, Rosenberg ES, Siegler AJ, et al. Challenges in translating PrEP interest into uptake in an observational study of young black MSM. J Acquir Immune Defic Syndr 1999. 2017;76(3):250\u20138. https:\/\/doi.org\/10.1097\/QAI.0000000000001497.","journal-title":"J Acquir Immune Defic Syndr 1999."},{"issue":"1","key":"7658_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s40274-017-4316-x","volume":"786","author":"Need for financial assistance for PrEP in USA","year":"2017","unstructured":"Need for financial assistance for PrEP in USA. PharmacoEcon Outcomes News. 2017;786(1):26\u201326. https:\/\/doi.org\/10.1007\/s40274-017-4316-x.","journal-title":"PharmacoEcon Outcomes News"},{"issue":"7","key":"7658_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25559","volume":"23","author":"SK Calabrese","year":"2020","unstructured":"Calabrese SK, Mayer KH. Stigma impedes HIV prevention by stifling patient-provider communication about U = U. J Int AIDS Soc. 2020;23(7): e25559. https:\/\/doi.org\/10.1002\/jia2.25559.","journal-title":"J Int AIDS Soc"},{"key":"7658_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/00918369.2020.1819709","author":"JP Zapata","year":"2020","unstructured":"Zapata JP, Petroll A, Aubin EDS, Quinn K. Perspectives on social support and stigma in PrEP-related care among gay and bisexual men: a qualitative investigation. J Homosex. 2020. https:\/\/doi.org\/10.1080\/00918369.2020.1819709.","journal-title":"J Homosex."},{"issue":"1","key":"7658_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1037\/ort0000117","volume":"86","author":"DM Frost","year":"2016","unstructured":"Frost DM, Meyer IH, Schwartz S. Social support networks among diverse sexual minority populations. Am J Orthopsychiatry. 2016;86(1):91\u2013102. https:\/\/doi.org\/10.1037\/ort0000117.","journal-title":"Am J Orthopsychiatry"},{"key":"7658_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.psyneuen.2014.05.013","volume":"47","author":"CL Burton","year":"2014","unstructured":"Burton CL, Bonanno GA, Hatzenbuehler ML. Familial social support predicts a reduced cortisol response to stress in sexual minority young adults. Psychoneuroendocrinology. 2014;47:241\u20135. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.05.013.","journal-title":"Psychoneuroendocrinology"},{"key":"7658_CR45","volume-title":"Coping with chronic illness: a cognitive-behavioral therapy approach for adherence and depression: therapist guide","author":"SA Safren","year":"2008","unstructured":"Safren SA, Gonzalez JS, Soroudi N. Coping with chronic illness: a cognitive-behavioral therapy approach for adherence and depression: therapist guide. Oxford: Oxford University Press; 2008."},{"issue":"1","key":"7658_CR46","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1177\/109019818601300108","volume":"13","author":"VJ Strecher","year":"1986","unstructured":"Strecher VJ, DeVellis BM, Becker MH, Rosenstock IM. The role of self-efficacy in achieving health behavior change. Health Educ Q. 1986;13(1):73\u201392. https:\/\/doi.org\/10.1177\/109019818601300108.","journal-title":"Health Educ Q"},{"issue":"1","key":"7658_CR47","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1037\/a0022023","volume":"30","author":"Y Teng","year":"2011","unstructured":"Teng Y, Mak WWS. The role of planning and self-efficacy in condom use among men who have sex with men: an application of the Health Action Process Approach model. Health Psychol. 2011;30(1):119\u201328. https:\/\/doi.org\/10.1037\/a0022023.","journal-title":"Health Psychol"},{"issue":"9","key":"7658_CR48","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1037\/hea0000617","volume":"37","author":"SA Safren","year":"2018","unstructured":"Safren SA, Blashill AJ, Lee JS, et al. Condom-use self-efficacy as a mediator between syndemics and condomless sex in men who have sex with men (MSM). Health Psychol. 2018;37(9):820\u20137. https:\/\/doi.org\/10.1037\/hea0000617.","journal-title":"Health Psychol"},{"issue":"10","key":"7658_CR49","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.2105\/AJPH.2015.302816","volume":"105","author":"SK Calabrese","year":"2015","unstructured":"Calabrese SK, Underhill K. How stigma surrounding the use of HIV preexposure prophylaxis undermines prevention and pleasure: a call to destigmatize \u201ctruvada whores.\u201d Am J Public Health. 2015;105(10):1960\u20134. https:\/\/doi.org\/10.2105\/AJPH.2015.302816.","journal-title":"Am J Public Health"},{"issue":"12","key":"7658_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081997","volume":"8","author":"JL Marcus","year":"2013","unstructured":"Marcus JL, Glidden DV, Mayer KH, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS ONE. 2013;8(12): e81997. https:\/\/doi.org\/10.1371\/journal.pone.0081997.","journal-title":"PLoS ONE"},{"issue":"7","key":"7658_CR51","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s10461-020-03148-x","volume":"25","author":"A Harkness","year":"2021","unstructured":"Harkness A, Rogers BG, Balise R, et al. Who aren\u2019t we reaching? Young sexual minority men\u2019s non-participation in an HIV-prevention and mental health clinical trial. AIDS Behav. 2021;25(7):2195\u2013209. https:\/\/doi.org\/10.1007\/s10461-020-03148-x.","journal-title":"AIDS Behav"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07658-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07658-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:36:04Z","timestamp":1660559764000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07658-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7658"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07658-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"26 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. Study procedures were approved by Institutional Review Boards at The Miriam Hospital, The University of Mississippi Medical Center, and Washington University School of Medicine. Written informed consent was obtained from all participants\u00a0and\/or their legal guardian(s).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"B.G.R. co-leads a Gilead Sciences grant to provide PrEP within the Rhode Island Department of Corrections: #IN-US-276-5463. Dr. Philip Chan is staff at Rhode Island Public Health Institute and consults for Rhode Island Department of Health. Dr. Leandro A. Mena reports the following consultant and research grants from Gilead Sciences, ViiV Healthcare\/Glaxo-Smith Kline, Merck, Roche and research grants from TaiMed and Janssen. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"673"}}